🕵️ Lifeward Ltd. ($LFWD)
SEC insider & ownership activity, last 12 months · CIK 1607962 · every row links its SEC filing
Over the last 12 months insiders sold $1K with no open-market buying against it. Lynch Jeannine sold $1K in discretionary trades (Sep). One red-flag 8-K in the window: Delisting notice (3.01), Mar 17, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $1K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Lynch Jeannine | 0 | – | 1 | $1K | Sep 2, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 49.9% | 13D | Mar 25, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 30, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Other events (8.01) | May 18, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Mar 25, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Earnings (2.02) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 10, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Feb 24, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 24, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 19, 2026 | filing ↗ |
| Other events (8.01) | Feb 19, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 12, 2026 | filing ↗ |
| New financial obligation (2.03) | Feb 12, 2026 | filing ↗ |
| Other events (8.01) | Feb 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 28, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jan 28, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 12, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 12, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 12, 2026 | filing ↗ |